Position in ENOV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,095,010
+$155,054 QoQ
Shares Held
294,445
+12.8% QoQ
Ownership
0.511%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#44
of 253 holders
Holding Since
Jun 2020
14 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ENOV Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $951,017,652 across 59 Medical Devices names. ENOV ranks #17 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
5,542,438 | $502,920,823 | |
| 2 | BSX |
Boston Scientific Corp
|
2,414,223 | $103,039,037 | |
| 3 | GKOS |
GLAUKOS Corp
|
314,804 | $43,997,006 | |
| 4 | DXCM |
Dexcom Inc
|
532,804 | $35,884,349 | |
| 5 | EW |
Edwards Lifesciences Corp
|
344,361 | $31,150,895 | |
| 6 | PEN |
Penumbra Inc
|
90,520 | $28,581,689 | |
| 7 | SYK |
Stryker Corp
|
51,116 | $16,093,361 | |
| 8 | GMED |
Globus Medical Inc
|
188,541 | $14,896,623 |
All Filings in ENOV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,095,010 | 294,445 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $5,939,956 | 261,097 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,763,914 | 66,213 | Shares | Other | 2026-02-13 | |
| 2024-12-31 | $6,210,468 | 141,533 | Shares | Other | 2025-02-13 | |
| 2024-03-31 | $576,226 | 9,227 | Shares | Other | 2024-05-15 | |
| 2023-06-30 | $8,010,832 | 124,935 | Shares | Other | 2023-08-14 | |
| 2022-09-30 | $670,364 | 14,551 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $975,205 | 17,731 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $4,569,008 | 114,828 | Shares | Other | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||